x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

Dexamethasone now key drug for local Covid-19 patients

Health & Science - By Gatonye Gathura | November 15th 2020 at 12:00:00 GMT +0300

Dexamethasone has become the drug of choice for treating severely ill coronavirus patients in Kenyan hospitals.

The first clinical study to be published by the Ministry of Health on the treatment of Covid-19 in Kenya says dexamethasone is the preferred drug in private and public hospitals.

“As more data become available, dexamethasone became standard of care for severely ill patients on oxygen or requiring mechanical ventilators,” reads the study published last Thursday on the online medRxiv platform.

The study led by Loice Achieng, head of infectious diseases unit at Kenyatta National Hospital (KNH), involved data from 787 Covid-19 patients treated in six public and private hospitals between March and September this year.

The hospitals included KNH, Mbagathi Hospital, Coast General Teaching and Referral Hospital, Nairobi Hospital, Aga Khan University Hospital and Avenue Hospital in Nairobi.

The research authors, including Director-General of Health Patrick Amoth, said by adopting dexamethasone, also known as Dexamed, local hospitals have stopped using earlier treatments such as the antibiotic azithromycin and the antimalarial hydroxychloroquine.

Dexamethasone, which is on Kenya’s list of essential medicines for the treatment of various common conditions including arthritis, allergies, asthma, blood, skin and other disorders is readily available, easy to use and reportedly cheaper than recent Covid-19 alternatives.

It comes in oral and injectable versions. A 10-day ampoule costs about Sh140 locally.

According to the World Health Organisation (WHO), Dexamethasone is a corticosteroid used in a wide range of conditions for its anti-inflammatory and immuno-suppressant effects.

It was tested in hospitalised patients with Covid-19 in the United Kingdom’s national clinical trial and was found to have benefits for critically ill patients.

According to preliminary findings shared with WHO, and now available as a pre-print, for patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth.

The new ministry report says the country is still experiencing problems accessing newer medications being used in rich countries such as remdesivir. “Access to novel antivirals is still poor in the country,” says the report.

Kills men

The 21-page study, however, has few new insights including some facts that the disease is less severe in Kenya and Africa than elsewhere.

It also asserts that it kills more men than women; kills much older persons and those with other chronic diseases.

“Almost half of the patients admitted in the six hospitals had other diseases, including heart conditions (17 per cent) diabetes (15 per cent), HIV (7 per cent), cancers (4 per cent), kidney disease (3 per cent) and respiratory ailments at three per cent,” reads the report.

On why men are dying more, the team suggests it may be because of their high risk behaviour including smoking and possibly other genetic differences yet to be identified.

It also suggests the disease may have been less severe in Kenya due to the younger population compared to America and Europe.

The study, however, recommends strategies be identified to protect older persons with chronic illnesses to minimise further loss of lives.

But even as the number of daily Covid 19 deaths hits a new high in the country, the Pharmacy and Poisons Board has approved the experimental use of radiation in the treatment of severe Covid-19 patients at the Aga Khan University Hospital in a new survey.

The study, which will involve 20 patients, will investigate whether low dose radiation therapy can be safely administered to patients with severe Covid-19, and if this can improve outcomes in critically ill patients.

At the same time, the first application in Kenya to conduct clinical trials on the use of herbal products derived from citrus fruits for the experimental treatment of Covid-19 is in the offing.

The application on WHO's global Covid products development tracker has been made by a little known group called EMKSE Phytochem and Thermosystems EA which is based in Nairobi. The group is proposing to work with Kenya Medical Research Institute to test its products on 200 participants.

Be The First To Comment

Top Stories

Why Covid jab got cold reception at airport
Health & Science - By Graham Kajilwa


Kenya receives Covid-19 vaccines
Health & Science - By Standard Team


How borehole water hurts your health
Health & Science - By Gatonye Gathura


Reluctance in uptake of Covid-19 vaccine
Health & Science - By Mercy Kahenda


331 test positive as Covid-19 vaccine roll-out set for Friday
Health & Science - By Mercy Asamba


Government to start distributing Covid-19 jabs
Health & Science - By Graham Kajilwa


CS Kagwe: Covid-19 vaccines will not be a Nairobi affair
Health & Science - By Graham Kajilwa


Four succumb to Covid-19 as Kenya records 345 positive cases
Health & Science - By Jael Mboga


Latest Stories

Why Covid jab got cold reception at airport
Health & Science - By Graham Kajilwa


UK regulator says will fast-track vaccines for coronavirus variants
Health & Science - By Reuters


President Uhuru flags off national distribution of Covid-19 vaccine
Health & Science - By Graham Kajilwa and Sara Okuoro


Reluctance in uptake of Covid-19 vaccine
Health & Science - By Mercy Kahenda


331 test positive as Covid-19 vaccine roll-out set for Friday
Health & Science - By Mercy Asamba


Government to start distributing Covid-19 jabs
Health & Science - By Graham Kajilwa


CS Kagwe: Covid-19 vaccines will not be a Nairobi affair
Health & Science - By Graham Kajilwa


Kenya receives Covid-19 vaccines
Health & Science - By Standard Team


Covid vaccines: Why this is an injection of politics
Health & Science - By Allan Mungai


People to watch in the distribution of Covid-19 jab
Health & Science - By Mercy Kahenda


//

Stay Ahead!

Access premium content only available
to our subscribers.

Or Login With Your Standard Account
Support independent journalism
×
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in